Kamada (KMDA) Change in Receivables (2012 - 2026)
Kamada's (KMDA) quarterly Change in Receivables came in at $1.3 million in Q1 2026, up 291.95% YoY from $328611.4 in Q1 2025, and down 70.03% on a QoQ basis from $4.3 million in Q4 2025.
Kamada (KMDA) Change in Receivables (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Change in Receivables data on file, last reported at $1.3 million in Q1 2026.
- Quarterly Change in Receivables rose 291.95% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 174.83% YoY) and the FY2025 annual result came in at -$535000.0, up 72.94% from the prior year.
- Change in Receivables declined to $1.3 million in Q1 2026, from $4.3 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $10.0 million in Q3 2024 to a low of -$7.4 million in Q2 2024.
- A 5-year average of $547165.1 and a median of $6306.0 in 2023 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 183385.58% in 2023, down 9620.04% in 2023.
- Tracing KMDA's Change in Receivables over 5 years: stood at -$3141.0 in 2022, then jumped by 183385.58% to $5.8 million in 2023, then tumbled by 190.78% to -$5.2 million in 2024, then surged by 182.24% to $4.3 million in 2025, then slumped by 70.03% to $1.3 million in 2026.
- The last three Change in Receivables figures came in at $1.3 million (Q1 2026), $4.3 million (Q4 2025), and -$1.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Kamada | 463.48 Mn | 434.00 Mn | 22.47 Mn | -191,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -191,000.00 |
| Jun 30, 2026 | -191,000.00 |
| Mar 31, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 4.30 Mn |
| Dec 31, 2025 | 4.30 Mn |
| Sep 30, 2025 | -1.04 Mn |
| Sep 30, 2025 | -1.04 Mn |
| Jun 30, 2025 | -2.11 Mn |
| Jun 30, 2025 | -2.11 Mn |
| Mar 31, 2025 | -671,000.00 |
| Mar 31, 2025 | -671,000.00 |
| Dec 31, 2024 | -5.23 Mn |
| Dec 31, 2024 | -5.23 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | -7.37 Mn |
| Jun 30, 2024 | -7.37 Mn |
| Mar 31, 2024 | 610,000.00 |
| Mar 31, 2024 | 610,000.00 |